about
Bacterial cellulose-based materials and medical devices: current state and perspectives.Evidence of the presence of 2-O-beta-D-xylopyranosyl-alpha-l-arabinofuranose side chains in barley husk arabinoxylan.Biomimetic engineering of cellulose-based materials.Cartilage Tissue Engineering by the 3D Bioprinting of iPS Cells in a Nanocellulose/Alginate Bioink.In situ imaging of collagen synthesis by osteoprogenitor cells in microporous bacterial cellulose scaffolds.Electrospun nanofibrous cellulose scaffolds with controlled microarchitecture.Biochemical and Structural Characterization of a Five-domain GH115 α-Glucuronidase from the Marine Bacterium Saccharophagus degradans 2-40T.In Vivo Chondrogenesis in 3D Bioprinted Human Cell-laden Hydrogel Constructs.Role of (1,3)(1,4)-β-glucan in cell walls: interaction with cellulose.A general route to xyloglucan-peptide conjugates for the activation of cellulose surfaces.In vitro evaluation of osteoblastic cells on bacterial cellulose modified with multi-walled carbon nanotubes as scaffold for bone regeneration.Novel bilayer bacterial nanocellulose scaffold supports neocartilage formation in vitro and in vivo.Increased lipid accumulation and adipogenic gene expression of adipocytes in 3D bioprinted nanocellulose scaffolds.Adipogenic differentiation of stem cells in three-dimensional porous bacterial nanocellulose scaffolds.Biosynthesis and in vitro evaluation of macroporous mineralized bacterial nanocellulose scaffolds for bone tissue engineering.Universal method for protein bioconjugation with nanocellulose scaffolds for increased cell adhesion.3D culturing and differentiation of SH-SY5Y neuroblastoma cells on bacterial nanocellulose scaffolds.Mechanical stimulation of fibroblasts in micro-channeled bacterial cellulose scaffolds enhances production of oriented collagen fibers.Behavior of human chondrocytes in engineered porous bacterial cellulose scaffolds.Biomimetic calcium phosphate crystal mineralization on electrospun cellulose-based scaffolds.Release of antithrombotic drugs from alginate gel beads.Mechanical properties of bacterial cellulose and interactions with smooth muscle cells.The feasibility of using irreversible electroporation to introduce pores in bacterial cellulose scaffolds for tissue engineering.Microporous bacterial cellulose as a potential scaffold for bone regeneration.Human adipose-derived stem cells contribute to chondrogenesis in coculture with human articular chondrocytes.Heterogeneous acylation of flax fibers. Reaction kinetics and surface properties.Coating modulus and barnacle bioadhesion.Surface modification of cellulose fibers: towards wood composites by biomimetics.Electromagnetically controlled biological assembly of aligned bacterial cellulose nanofibers.Quartz crystal microbalance with dissipation monitoring and surface plasmon resonance studies of carboxymethyl cellulose adsorption onto regenerated cellulose surfaces.Material properties of plasticized hardwood xylans for potential application as oxygen barrier films.(13)C NMR assignments of regenerated cellulose from solid-state 2D NMR spectroscopy.Material properties of films from enzymatically tailored arabinoxylans.Effect of cell seeding concentration on the quality of tissue engineered constructs loaded with adult human articular chondrocytes.Fouling-release coatings prepared from alpha,omega-dihydroxypoly(dimethylsiloxane) cross-linked with (heptadecafluoro-1,1,2,2-tetrahydrodecyl)triethoxysilane.Effect of arabinose substitution on the material properties of arabinoxylan films.Modification of nanocellulose with a xyloglucan-RGD conjugate enhances adhesion and proliferation of endothelial cells: implications for tissue engineering.Chondrocytes and stem cells in 3D-bioprinted structures create human cartilage in vivo.Biomimetic Inks Based on Cellulose Nanofibrils and Cross-Linkable Xylans for 3D Printing.Engineering microporosity in bacterial cellulose scaffolds.
P50
Q30453864-F9AEE1AE-902B-43FB-ABD9-CA8941EB4EF6Q33262534-D5B75E45-B7D9-4FDD-AA31-F0990BF382E0Q33285084-D23A1D25-EB98-4DD7-8979-4557381E05F1Q33674174-F55D6B82-F209-4D4B-9D68-C014EEF321BBQ34051429-E59A1EB5-50BB-4623-9F55-EBFD6DEE9B69Q35031540-1713F560-0B94-41E5-8A71-B830091240A6Q37065728-BFEDEF89-8309-4C9A-8AB6-BAFA589DC142Q37684953-067A5B08-D5D6-42DA-AAC9-CEDF90B9C014Q38308137-9CE79DB4-A187-4FCA-AEC4-9BE3ACC6B5B6Q38325758-63C5FA74-B40F-42BB-BC24-09562FBFB8F7Q38707297-CB822686-9587-47C7-973E-35A2895B2302Q38916959-669C9B64-004D-4799-B954-C907604625F5Q38989883-8D471A7D-8941-481F-B373-C0B12E2EC0FFQ38995835-6C611D35-E690-4EAC-A22E-7BAF5BD5E7D6Q39059589-73697D86-532B-4F3E-9370-31D9106C17AAQ39086788-C6BB83AD-199E-4969-8051-D7EC6EEA1FB2Q39118797-8E69F3E3-0E75-4B9B-A0C4-8401F4BB995FQ39660312-8630685E-EDCE-4ECF-BDD2-36982B2C90DAQ39669621-9F0B891C-15EE-41F3-A7B6-3D174EC6C902Q39778245-459B65CF-A5D0-4C64-8D00-3BAEA2C55300Q39849186-7837C75A-5D3E-48DF-99C9-E7BA64C69842Q40369824-3A4A681B-511B-4FCA-886D-11715630413BQ40854979-32021B46-FD76-4189-9706-6B9C69B4AAC5Q42830574-F75AB699-9435-4CDC-9E2B-86303C038579Q44223045-1998AB8C-6EA9-41F1-88EA-C8714FB1A91DQ44437397-4B39CDF8-6342-44BC-B4FE-52A575AAC10EQ44656445-1C85BD4F-CA23-40FC-8133-0329D012BA04Q44906967-EE59EDE5-4FBA-4049-9182-2B85724C2B94Q44955213-40294050-B7D1-41A1-B31E-8FB748FB85E6Q44967088-1D78C76E-58C1-4BA3-9269-889125C11DE3Q44971312-49618AB4-932C-44DC-8682-3022E1847CFCQ46508451-4AEA0BE9-B23E-44AA-950C-54CF28B7CAB7Q46524013-BA2C8210-C2A6-4546-B6E3-518AAFB3AD01Q46760863-816F9690-E983-4C99-A721-F1A4BFF4598DQ46779937-20E68795-52CF-457B-8CDB-3352C9F6E483Q46799862-E7C4309A-6D5F-4924-A7A4-90094EFD77C3Q46887654-A5D6C7A1-9C9A-4EDD-ADB8-B12A5267C375Q47106809-93D7247C-89B1-41B4-ABEB-8B42CB43B677Q47412325-1552218C-5B1B-4C78-9E4E-76AB4FCFDD3BQ47584015-D2B1D9E4-1E75-404D-A6DD-C0F39357DC04
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究者
@zh
name
Paul Gatenholm
@ast
Paul Gatenholm
@en
Paul Gatenholm
@es
Paul Gatenholm
@nl
type
label
Paul Gatenholm
@ast
Paul Gatenholm
@en
Paul Gatenholm
@es
Paul Gatenholm
@nl
prefLabel
Paul Gatenholm
@ast
Paul Gatenholm
@en
Paul Gatenholm
@es
Paul Gatenholm
@nl
P214
P214
P31
P496
0000-0002-5107-0389
P735
P7859
lccn-n2003010826